Great expectations. How do the new drugs measure up?

Scalable Production of Equine Platelet Lysate for Multipotent Mesenchymal Stromal Cell Culture.

Frontiers in bioengineering and biotechnology·2021

Comparison between adult and foetal adnexa derived equine post-natal mesenchymal stem cells.

BMC veterinary research·2019

'Say no': a feasibility trial of a brief intervention to reduce instances of indulgent energy-intake episodes.

Clinical obesity·2018

Effects of mesenchymal stromal cells versus serum on tendon healing in a controlled experimental trial in an equine model.

BMC musculoskeletal disorders·2018

Characterisation and intracellular labelling of mesenchymal stromal cells derived from synovial fluid of horses and sheep.

Veterinary journal (London, England : 1997)·2017

Parametrization of nanoparticles: development of full-particle nanodescriptors.

Nanoscale·2016

The "War" Between Aging and Dying.

The American journal of nursing·2026

Stillbirths Occur in the U.S. More Often Than Reported.

The American journal of nursing·2026

Psychosocial Support for Children with Cancer Varies Across Pediatric Cancer Programs.

The American journal of nursing·2026

Trump Administration Challenges Protections for Consumers with Medical Debt.

The American journal of nursing·2026

Direct Care Workers Hover at the Poverty Line.

The American journal of nursing·2026

The Vet.

The American journal of nursing·2026

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Cureus·2026

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Frontiers in endocrinology·2026

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Canadian journal of kidney health and disease·2026

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Frontiers in pharmacology·2026

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Frontiers in molecular neuroscience·2026

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Therapeutic advances in neurological disorders·2026

Related Experiment Videos

Great expectations. How do the new drugs measure up?

Related Concept Videos

Scalable Production of Equine Platelet Lysate for Multipotent Mesenchymal Stromal Cell Culture.

Comparison between adult and foetal adnexa derived equine post-natal mesenchymal stem cells.

'Say no': a feasibility trial of a brief intervention to reduce instances of indulgent energy-intake episodes.

Effects of mesenchymal stromal cells versus serum on tendon healing in a controlled experimental trial in an equine model.

Characterisation and intracellular labelling of mesenchymal stromal cells derived from synovial fluid of horses and sheep.

Parametrization of nanoparticles: development of full-particle nanodescriptors.

The "War" Between Aging and Dying.

Stillbirths Occur in the U.S. More Often Than Reported.

Psychosocial Support for Children with Cancer Varies Across Pediatric Cancer Programs.

Trump Administration Challenges Protections for Consumers with Medical Debt.

Direct Care Workers Hover at the Poverty Line.

The Vet.

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Related Experiment Videos

Great expectations. How do the new drugs measure up?

Related Concept Videos

Related Articles